North America Bioproduction Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), and End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others)

No. of Pages: 95    |    Report Code: BMIRE00030058    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Bioproduction Market

1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           North America Bioproduction Market - Key Industry Dynamics

4.1       Market Drivers

4.1.1         Rising Adoption of Regenerative Medicines

4.1.2         Increasing Prevalence of Chronic Diseases

4.2       Market Restraints

4.2.1         High Cost of Cell Therapy and Biosimilar Manufacturing

4.3       Market Opportunities

4.3.1         Patent Expiry of Blockbuster Biologics

4.4       Future Trends

4.4.1         Shift Toward Automated Cell Therapy Manufacturing

4.5       Impact Analysis

5.           Bioproduction Market - North America Market Analysis

5.1       North America Bioproduction Market Revenue (US$ Mn), 2020 – 2030

6.           North America Bioproduction Market – Revenue and Forecast to 2030 – by Product

6.1       Overview

6.2       North America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)

6.3       Biologics and Biosimilars

6.3.1         Overview

6.3.2         Biologics and Biosimilars: North America Bioproduction Market – Revenue and Forecast to 2030  (US$ Million)

6.4       Vaccines

6.4.1         Overview

6.4.2         Vaccines:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

6.5       Cell and Gene Therapies

6.5.1         Overview

6.5.2         Cell and Gene Therapies:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

6.6       Nucleic Acid Therapeutics

6.6.1         Overview

6.6.2         Nucleic Acid Therapeutics:  North America Bioproduction Market – Revenue and Forecast to 2030  (US$ Million)

6.7       Others

6.7.1         Overview

6.7.2         Others:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

7.           North America Bioproduction Market – Revenue and Forecast to 2030 – by Application

7.1       Overview

7.2       North America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)

7.3       Cancer

7.3.1         Overview

7.3.2         Cancer: North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

7.4       Cardiovascular Diseases

7.4.1         Overview

7.4.2         Cardiovascular Diseases:  North America Bioproduction Market – Revenue and Forecast to 2030  (US$ Million)

7.5       Rheumatoid Arthritis

7.5.1         Overview

7.5.2         Rheumatoid Arthritis:  North America Bioproduction Market – Revenue and Forecast to 2030  (US$ Million)

7.6       Hematological Disorders

7.6.1         Overview

7.6.2         Hematological Disorders:  North America Bioproduction Market – Revenue and Forecast to 2030  (US$ Million)

7.7       Diabetes

7.7.1         Overview

7.7.2         Diabetes:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

7.8       Others

7.8.1         Overview

7.8.2         Others:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

8.           North America Bioproduction Market – Revenue and Forecast to 2030 – by Equipment

8.1       Overview

8.2       North America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)

8.3       Consumables and Accessories

8.3.1         Overview

8.3.2         Consumables and Accessories:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

8.4       Downstream Equipment

8.4.1         Overview

8.4.2         Downstream Equipment:  North America Bioproduction Market – Revenue and Forecast to 2030  (US$ Million)

8.5       Bioreactors

8.5.1         Overview

8.5.2         Bioreactors:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

8.5.2.1            North America: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)

8.6       Upstream Equipment

8.6.1         Overview

8.6.2         Upstream Equipment:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

9.           North America Bioproduction Market – Revenue and Forecast to 2030 – by End User

9.1       Overview

9.2       North America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)

9.3       Biopharmaceutical Companies

9.3.1         Overview

9.3.2         Biopharmaceutical Companies:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

9.4       Contract Manufacturing Organizations

9.4.1         Overview

9.4.2         Contract Manufacturing Organizations:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

9.5       Others

9.5.1         Overview

9.5.2         Others:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

10.        North America Bioproduction Market – Revenue and Forecast to 2030 – Country Analysis

10.1     North America: Bioproduction Market

10.1.1             US:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1            Overview

10.1.1.2            US:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3            US: Bioproduction Market, by Product, 2020–2030 (US$ Million)

10.1.1.4            US: Bioproduction Market, by Application, 2020–2030 (US$ Million)

10.1.1.5            US: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)

10.1.1.5.1            US: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)

10.1.1.6            US: Bioproduction Market, by End User, 2020–2030 (US$ Million)

10.1.1.2          Canada:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1        Overview

10.1.1.2.2        Canada:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.3        Canada: Bioproduction Market, by Product, 2020–2030 (US$ Million)

10.1.1.2.4        Canada: Bioproduction Market, by Application, 2020–2030 (US$ Million)

10.1.1.2.5        Canada: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)

10.1.1.2.5.1        Canada: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)

10.1.1.2.6        Canada: Bioproduction Market, by End User, 2020–2030 (US$ Million)

10.1.1.3          Mexico:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1        Overview

10.1.1.3.2        Mexico:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.3        Mexico: Bioproduction Market, by Product, 2020–2030 (US$ Million)

10.1.1.3.4        Mexico: Bioproduction Market, by Application, 2020–2030 (US$ Million)

10.1.1.3.5        Mexico: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)

10.1.1.3.5.1        Mexico: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)

10.1.1.3.6        Mexico: Bioproduction Market, by End User, 2020–2030 (US$ Million)

11.        Bioproduction Market–Industry Landscape

11.1     Overview

11.2     Growth Strategies in the Bioproduction Market

11.3     Inorganic Growth Strategies

11.3.1       Overview

11.4     Organic Growth Strategies

11.4.1       Overview

12.     Company Profiles

12.1     Lonza Group AG

12.1.1       Key Facts

12.1.2       Business Description

12.1.3       Products and Services

12.1.4       Financial Overview

12.1.5       SWOT Analysis

12.1.6       Key Developments

12.2     Danaher Corp

12.2.1       Key Facts

12.2.2       Business Description

12.2.3       Products and Services

12.2.4       Financial Overview

12.2.5       SWOT Analysis

12.2.6       Key Developments

12.3     Sartorius AG

12.3.1       Key Facts

12.3.2       Business Description

12.3.3       Products and Services

12.3.4       Financial Overview

12.3.5       SWOT Analysis

12.3.6       Key Developments

12.4     Thermo Fisher Scientific Inc

12.4.1       Key Facts

12.4.2       Business Description

12.4.3       Products and Services

12.4.4       Financial Overview

12.4.5       SWOT Analysis

12.4.6       Key Developments

12.5     Merck KGaA

12.5.1       Key Facts

12.5.2       Business Description

12.5.3       Products and Services

12.5.4       Financial Overview

12.5.5       SWOT Analysis

12.5.6       Key Developments

12.6     F. Hoffmann-La Roche Ltd

12.6.1       Key Facts

12.6.2       Business Description

12.6.3       Products and Services

12.6.4       Financial Overview

12.6.5       SWOT Analysis

12.6.6       Key Developments

12.7     Bio-Rad Laboratories Inc

12.7.1       Key Facts

12.7.2       Business Description

12.7.3       Products and Services

12.7.4       Financial Overview

12.7.5       SWOT Analysis

12.7.6       Key Developments

13.        Appendix

13.1     About Us

13.2     Glossary of Terms

 

 

 

 

List of Tables

Table 1.             North America Bioproduction Market Segmentation

Table 2.             North America Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030  (US$ Million)

Table 3.             US Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 4.             US Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 5.             US Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)

Table 6.             US Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)

Table 7.             US Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 8.             Canada Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 9.             Canada Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 10.          Canada Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)

Table 11.          Canada Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)

Table 12.          Canada Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 13.          Mexico Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)

Table 14.          Mexico Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 15.          Mexico Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)

Table 16.          Mexico Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)

Table 17.          Mexico Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 18.          Recent Inorganic Growth Strategies in the Bioproduction Market

Table 19.          Recent Organic Growth Strategies in the Bioproduction Market

Table 20.          Glossary of Terms, Bioproduction Market

 

 

List of Figures

Figure 1.           North America Bioproduction Market Segmentation, By Country

Figure 2.           North America Bioproduction Market: Key Industry Dynamics

Figure 3.           North America Bioproduction Market: Impact Analysis of Drivers and Restraints

Figure 4.           North America Bioproduction Market Revenue (US$ Mn), 2020 – 2030

Figure 5.           North America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)

Figure 6.           Biologics and Biosimilars:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 7.           Vaccines:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 8.           Cell and Gene Therapies:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9.           Nucleic Acid Therapeutics:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 10.        Others:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11.        North America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)

Figure 12.        Cancer:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13.        Cardiovascular Diseases:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 14.        Rheumatoid Arthritis:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 15.        Hematological Disorders:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 16.        Diabetes:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 17.        Others:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 18.        North America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)

Figure 19.        Consumables and Accessories:  North America Bioproduction Market – Revenue and Forecast to 2030  (US$ Million)

Figure 20.        Downstream Equipment:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21.        Bioreactors:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 22.        Upstream Equipment:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 23.        North America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)

Figure 24.        Biopharmaceutical Companies:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 25.        Contract Manufacturing Organizations:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 26.        Others:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 27.        North America: Bioproduction Market, by Key Country – Revenue (2022) (US$ Million)

Figure 28.        North America: Bioproduction Market, by Country, 2022 & 2030 (%)

Figure 29.        US:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 30.        Canada:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 31.        Mexico:  North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

Figure 32.             Growth Strategies in the Bioproduction Market

The List of Companies - North America Bioproduction Market

1. Bio-Rad Laboratories Inc

2. Danaher Corp

3. F. Hoffmann-La Roche Ltd

4. Lonza Group AG

5. Merck KGaA

6. Sartorius AG

7. Thermo Fisher Scientific Inc